145 related articles for article (PubMed ID: 19242112)
21. TGFbeta-mediated apoptosis of Burkitt's lymphoma BL41 cells is associated with the relocation of mitochondrial BimEL.
Clybouw C; Mchichi BE; Hadji A; Portier A; Auffredou MT; Arnoult D; Leca G; Vazquez A
Oncogene; 2008 May; 27(24):3446-56. PubMed ID: 18193085
[TBL] [Abstract][Full Text] [Related]
22. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway.
Craxton A; Draves KE; Gruppi A; Clark EA
J Exp Med; 2005 Nov; 202(10):1363-74. PubMed ID: 16301744
[TBL] [Abstract][Full Text] [Related]
23. Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification.
Okamoto W; Okamoto I; Arao T; Kuwata K; Hatashita E; Yamaguchi H; Sakai K; Yanagihara K; Nishio K; Nakagawa K
Mol Cancer Ther; 2012 Jul; 11(7):1557-64. PubMed ID: 22729845
[TBL] [Abstract][Full Text] [Related]
24. Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines.
Li H; Zhou S; Li X; Wang D; Wang Y; Zhou C; Schmid-Bindert G
Cancer Biother Radiopharm; 2013 Mar; 28(2):115-23. PubMed ID: 23270470
[TBL] [Abstract][Full Text] [Related]
25. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
[TBL] [Abstract][Full Text] [Related]
26. 8‑bromo‑7‑methoxychrysin induces apoptosis by regulating Akt/FOXO3a pathway in cisplatin‑sensitive and resistant ovarian cancer cells.
Ding Q; Chen Y; Zhang Q; Guo Y; Huang Z; Dai L; Cao S
Mol Med Rep; 2015 Oct; 12(4):5100-8. PubMed ID: 26151347
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells.
Guan H; Song L; Cai J; Huang Y; Wu J; Yuan J; Li J; Li M
PLoS One; 2011; 6(5):e19946. PubMed ID: 21625639
[TBL] [Abstract][Full Text] [Related]
28. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
Way TD; Kao MC; Lin JK
J Biol Chem; 2004 Feb; 279(6):4479-89. PubMed ID: 14602723
[TBL] [Abstract][Full Text] [Related]
29. Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth.
Normanno N; Campiglio M; De LA; Somenzi G; Maiello M; Ciardiello F; Gianni L; Salomon DS; Menard S
Ann Oncol; 2002 Jan; 13(1):65-72. PubMed ID: 11863114
[TBL] [Abstract][Full Text] [Related]
30. Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism.
Roberts CG; Gurisik E; Biden TJ; Sutherland RL; Butt AJ
Mol Cancer Ther; 2007 Oct; 6(10):2777-85. PubMed ID: 17913853
[TBL] [Abstract][Full Text] [Related]
31. FOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis.
Wang J; Liu S; Yin Y; Li M; Wang B; Yang L; Jiang Y
Apoptosis; 2015 Mar; 20(3):399-409. PubMed ID: 25501496
[TBL] [Abstract][Full Text] [Related]
32. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL
Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956
[TBL] [Abstract][Full Text] [Related]
33. BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors.
Faber AC; Corcoran RB; Ebi H; Sequist LV; Waltman BA; Chung E; Incio J; Digumarthy SR; Pollack SF; Song Y; Muzikansky A; Lifshits E; Roberge S; Coffman EJ; Benes CH; Gómez HL; Baselga J; Arteaga CL; Rivera MN; Dias-Santagata D; Jain RK; Engelman JA
Cancer Discov; 2011 Sep; 1(4):352-65. PubMed ID: 22145099
[TBL] [Abstract][Full Text] [Related]
34. EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
Nalluri S; Peirce SK; Tanos R; Abdella HA; Karmali D; Hogarty MD; Goldsmith KC
Cancer Biol Ther; 2015; 16(2):276-86. PubMed ID: 25756510
[TBL] [Abstract][Full Text] [Related]
35. Nerve growth factor blocks thapsigargin-induced apoptosis at the level of the mitochondrion via regulation of Bim.
Szegezdi E; Herbert KR; Kavanagh ET; Samali A; Gorman AM
J Cell Mol Med; 2008 Dec; 12(6A):2482-96. PubMed ID: 18266951
[TBL] [Abstract][Full Text] [Related]
36. H2AX phosphorylation regulated by p38 is involved in Bim expression and apoptosis in chronic myelogenous leukemia cells induced by imatinib.
Dong Y; Xiong M; Duan L; Liu Z; Niu T; Luo Y; Wu X; Xu C; Lu C
Apoptosis; 2014 Aug; 19(8):1281-92. PubMed ID: 24830786
[TBL] [Abstract][Full Text] [Related]
37. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.
Squires MS; Hudson EA; Howells L; Sale S; Houghton CE; Jones JL; Fox LH; Dickens M; Prigent SA; Manson MM
Biochem Pharmacol; 2003 Feb; 65(3):361-76. PubMed ID: 12527329
[TBL] [Abstract][Full Text] [Related]
38. Insulin receptor substrate-1 and -2 mediate resistance to glucose-induced caspase-3 activation in human neuroblastoma cells.
Stöhr O; Hahn J; Moll L; Leeser U; Freude S; Bernard C; Schilbach K; Markl A; Udelhoven M; Krone W; Schubert M
Biochim Biophys Acta; 2011 May; 1812(5):573-80. PubMed ID: 21354306
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.
Cuello M; Ettenberg SA; Clark AS; Keane MM; Posner RH; Nau MM; Dennis PA; Lipkowitz S
Cancer Res; 2001 Jun; 61(12):4892-900. PubMed ID: 11406568
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer.
Nam HJ; Im SA; Oh DY; Elvin P; Kim HP; Yoon YK; Min A; Song SH; Han SW; Kim TY; Bang YJ
Mol Cancer Ther; 2013 Jan; 12(1):16-26. PubMed ID: 23144237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
